At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
blood sample +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children in Assiut University Children Hospital
In Brief
An observational study evaluating blood sample and Tricuspid regurge velocity for Thalassemia in Children and 2 related conditions. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The study will investigate the relation between erythrocyte glutamine/glutamate ratio and pulmonary hypertension risk in Egyptian thalassemic children in Assiut University Children Hospital
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsThalassemia in Children, Pulmonary Hypertension, Hemolysis
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 2017
Enrollment StartJun 2017
Primary CompletionAug 2019
Study CompletionAug 2019
TodayJul 2026
First PostedApr 28, 2017
Enrollment StartJun 1, 2017
Primary CompletionAug 25, 2019
Study CompletionAug 26, 2019
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 9.2 years ago
Interventions
blood sampleother
blood sample for measuring liver and kidney function, CBC, ferritin level and erythrocyte glutamine level
Tricuspid regurge velocityother
Tricuspid regurge velocity will be measured by doppler echocardiography denoting the pulmonary hypertension risk in children